Skip to main content
Top
Published in: Journal of Clinical Immunology 8/2014

01-11-2014 | Astute Clinician Report

The First US Domestic Report of Disseminated Mycobacterium avium Complex and Anti-Interferon-γ Autoantibodies

Authors: Elise O’Connell, Lindsey B. Rosen, Richard W. LaRue, Valeria Fabre, Michael T. Melia, Paul G. Auwaerter, Steven M. Holland, Sarah K. Browne

Published in: Journal of Clinical Immunology | Issue 8/2014

Login to get access

Abstract

Introduction

Anti-interferon-γ (IFNγ) autoantibodies have been associated with disseminated mycobacterial infections, mostly in patients from Southeast Asia.

Purpose

We studied an American-born, Caucasian female with M. avium complex infection of the subglottic mucosa and brain for underlying etiologies of infection.

Methods

Plasma was screened for anticytokine autoantibodies using a Luminex-based approach. The ability of patient plasma to block IFNγ-induced STAT1 phosphorylation in normal blood cells was evaluated by flow cytometry with intracellular staining. Plasma inhibition of IFNγ production and IFNγ-induced cytokines in normal and patient blood cells washed of autologous plasma was also evaluated.

Results

Patient plasma contained high-titer IgG anti-IFNγ autoantibodies, primarily of the IgG1 subclass. Patient but not control plasma prevented IFNγ-induced STAT1 phosphorylation and expression of the IFNγ-inducible cytokines tumor necrosis factor (TNF) α and interleukin (IL)-12 in normal blood cells. Patient blood cells washed free of autologous plasma demonstrated normal IFNγ production and response.

Conclusions

Disseminated nontuberculous mycobacterial infections should always prompt immune evaluation. This first case of disseminated nontuberculous mycobacterial infection and anti-IFNγ autoantibodies in an American-born Caucasian suggests that anti-cytokine autoantibodies are not racially or regionally restricted.
Literature
1.
go back to reference Browne SK, Burbelo PD, Chetchotisakd P, Suputtamongkol Y, Kiertiburanakul S, Shaw PA, et al. Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med. 2012;367(8):725–34.PubMedCentralPubMedCrossRef Browne SK, Burbelo PD, Chetchotisakd P, Suputtamongkol Y, Kiertiburanakul S, Shaw PA, et al. Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med. 2012;367(8):725–34.PubMedCentralPubMedCrossRef
2.
go back to reference Patel SY, Ding L, Brown MR, Lantz L, Gay T, Cohen S, et al. Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections. J Immunol. 2005;175(7):4769–76.PubMedCrossRef Patel SY, Ding L, Brown MR, Lantz L, Gay T, Cohen S, et al. Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections. J Immunol. 2005;175(7):4769–76.PubMedCrossRef
3.
go back to reference Koya T, Tsubata C, Kagamu H, Koyama K, Hayashi M, Kuwabara K, et al. Anti-interferon-gamma autoantibody in a patient with disseminated mycobacterium avium complex. J Infect Chemother Off J Jpn Soc Chemother. 2009;15(2):118–22.CrossRef Koya T, Tsubata C, Kagamu H, Koyama K, Hayashi M, Kuwabara K, et al. Anti-interferon-gamma autoantibody in a patient with disseminated mycobacterium avium complex. J Infect Chemother Off J Jpn Soc Chemother. 2009;15(2):118–22.CrossRef
4.
go back to reference Doffinger R, Helbert MR, Barcenas-Morales G, Yang K, Dupuis S, Ceron-Gutierrez L, et al. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clin Infect Dis Off Publ Infect Dis Soc Am. 2004;38(1):e10–4.CrossRef Doffinger R, Helbert MR, Barcenas-Morales G, Yang K, Dupuis S, Ceron-Gutierrez L, et al. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clin Infect Dis Off Publ Infect Dis Soc Am. 2004;38(1):e10–4.CrossRef
5.
go back to reference Chih-Yu Chi C-CC, Jing-Pei L, Chia-Hao L, Mao-Wang H, Wen-Jyi L, Po-Chang L, et al. Anti−IFN-γ autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection. Blood. 2013;121(8):1357–66.PubMedCrossRef Chih-Yu Chi C-CC, Jing-Pei L, Chia-Hao L, Mao-Wang H, Wen-Jyi L, Po-Chang L, et al. Anti−IFN-γ autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection. Blood. 2013;121(8):1357–66.PubMedCrossRef
6.
go back to reference Ding Q, Yeung M, Camirand G, Zeng Q, Akiba H, Yagita H, et al. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J Clin Invest. 2011;121(9):3645–56.PubMedCentralPubMedCrossRef Ding Q, Yeung M, Camirand G, Zeng Q, Akiba H, Yagita H, et al. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J Clin Invest. 2011;121(9):3645–56.PubMedCentralPubMedCrossRef
7.
go back to reference Holland SM, Dorman SE, Kwon A, Pitha-Rowe IF, Frucht DM, Gerstberger SM, et al. Abnormal regulation of interferon-gamma, interleukin-12, and tumor necrosis factor-alpha in human interferon-gamma receptor 1 deficiency. J Infect Dis. 1998;178(4):1095–104.PubMedCrossRef Holland SM, Dorman SE, Kwon A, Pitha-Rowe IF, Frucht DM, Gerstberger SM, et al. Abnormal regulation of interferon-gamma, interleukin-12, and tumor necrosis factor-alpha in human interferon-gamma receptor 1 deficiency. J Infect Dis. 1998;178(4):1095–104.PubMedCrossRef
8.
go back to reference Browne SK. Anticytokine autoantibody-associated immunodeficiency. Annu Rev Immunol. 2014;32:635–57.PubMedCrossRef Browne SK. Anticytokine autoantibody-associated immunodeficiency. Annu Rev Immunol. 2014;32:635–57.PubMedCrossRef
9.
go back to reference Kampmann B, Hemingway C, Stephens A, Davidson R, Goodsall A, Anderson S, et al. Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma. J Clin Invest. 2005;115(9):2480–8.PubMedCentralPubMedCrossRef Kampmann B, Hemingway C, Stephens A, Davidson R, Goodsall A, Anderson S, et al. Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma. J Clin Invest. 2005;115(9):2480–8.PubMedCentralPubMedCrossRef
10.
go back to reference Rosen LB, Freeman AF, Yang LM, Jutivorakool K, Olivier KN, Angkasekwinai N, et al. Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis. J Immunol (Baltimore Md 1950). 2013;190(8):3959–66.CrossRef Rosen LB, Freeman AF, Yang LM, Jutivorakool K, Olivier KN, Angkasekwinai N, et al. Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis. J Immunol (Baltimore Md 1950). 2013;190(8):3959–66.CrossRef
11.
go back to reference De Francesco MA, Caruso A, Dima F, Cantalamessa A, Canaris AD, Folghera S, et al. IFN-gamma restores HIV- and non-HIV-specific cell mediated immune response in vitro and its activity is neutralized by antibodies from patients with AIDS. Scand J Immunol. 1996;43(1):94–100.PubMedCrossRef De Francesco MA, Caruso A, Dima F, Cantalamessa A, Canaris AD, Folghera S, et al. IFN-gamma restores HIV- and non-HIV-specific cell mediated immune response in vitro and its activity is neutralized by antibodies from patients with AIDS. Scand J Immunol. 1996;43(1):94–100.PubMedCrossRef
12.
go back to reference Caruso A, Foresti I, Gribaudo G, Bonfanti C, Pollara P, Dolei A, et al. Anti-interferon-gamma antibodies in sera from HIV infected patients. J Biol Regul Homeost Agents. 1989;3(1):8–12.PubMed Caruso A, Foresti I, Gribaudo G, Bonfanti C, Pollara P, Dolei A, et al. Anti-interferon-gamma antibodies in sera from HIV infected patients. J Biol Regul Homeost Agents. 1989;3(1):8–12.PubMed
13.
go back to reference Caruso A, Bonfanti C, Colombrita D, De Francesco M, De Rango C, Foresti I, et al. Natural antibodies to IFN-gamma in man and their increase during viral infection. J Immunol (Baltimore Md 1950). 1990;144(2):685–90. Caruso A, Bonfanti C, Colombrita D, De Francesco M, De Rango C, Foresti I, et al. Natural antibodies to IFN-gamma in man and their increase during viral infection. J Immunol (Baltimore Md 1950). 1990;144(2):685–90.
14.
go back to reference Bonfanti C, Caruso A, Bakhiet M, Olsson T, Turano A, Kristensson K. Increased levels of antibodies to IFN-gamma in human and experimental African trypanosomiasis. Scand J Immunol. 1995;41(1):49–52.PubMedCrossRef Bonfanti C, Caruso A, Bakhiet M, Olsson T, Turano A, Kristensson K. Increased levels of antibodies to IFN-gamma in human and experimental African trypanosomiasis. Scand J Immunol. 1995;41(1):49–52.PubMedCrossRef
15.
go back to reference Madariaga L, Amurrio C, Martin G, Garcia-Cebrian F, Bicandi J, Lardelli P, et al. Detection of anti-interferon-gamma autoantibodies in subjects infected by mycobacterium tuberculosis. Int J Tuberc Lung Dis Off J Int Union against Tuberc Lung Dis. 1998;2(1):62–8. Madariaga L, Amurrio C, Martin G, Garcia-Cebrian F, Bicandi J, Lardelli P, et al. Detection of anti-interferon-gamma autoantibodies in subjects infected by mycobacterium tuberculosis. Int J Tuberc Lung Dis Off J Int Union against Tuberc Lung Dis. 1998;2(1):62–8.
16.
go back to reference Wildbaum G, Nahir MA, Karin N. Beneficial autoimmunity to proinflammatory mediators restrains the consequences of self-destructive immunity. Immunity. 2003;19(5):679–88.PubMedCrossRef Wildbaum G, Nahir MA, Karin N. Beneficial autoimmunity to proinflammatory mediators restrains the consequences of self-destructive immunity. Immunity. 2003;19(5):679–88.PubMedCrossRef
17.
18.
go back to reference McEwan JA, Mohsen AH, Schmid ML, McKendrick MW. A hoarse voice: atypical mycobacterial infection of the larynx. J Laryngol Otol. 2001;115(11):920–2.PubMedCrossRef McEwan JA, Mohsen AH, Schmid ML, McKendrick MW. A hoarse voice: atypical mycobacterial infection of the larynx. J Laryngol Otol. 2001;115(11):920–2.PubMedCrossRef
19.
go back to reference Wang BY, Amolat MJ, Woo P, Brandwein-Gensler M. Atypical mycobacteriosis of the larynx: an unusual clinical presentation secondary to steroids inhalation. Ann Diagn Pathol. 2008;12(6):426–9.PubMedCrossRef Wang BY, Amolat MJ, Woo P, Brandwein-Gensler M. Atypical mycobacteriosis of the larynx: an unusual clinical presentation secondary to steroids inhalation. Ann Diagn Pathol. 2008;12(6):426–9.PubMedCrossRef
20.
go back to reference Sadek M, Yue FY, Lee EY, Gyenes G, Jones RB, Hoffstein V, et al. Clinical and immunologic features of an atypical intracranial mycobacterium avium complex (MAC) infection compared with those of pulmonary MAC infections. Clin Vaccine Immunol CVI. 2008;15(10):1580–9.CrossRef Sadek M, Yue FY, Lee EY, Gyenes G, Jones RB, Hoffstein V, et al. Clinical and immunologic features of an atypical intracranial mycobacterium avium complex (MAC) infection compared with those of pulmonary MAC infections. Clin Vaccine Immunol CVI. 2008;15(10):1580–9.CrossRef
21.
go back to reference Dickerman RD, Stevens QE, Rak R, Dorman SE, Holland SM, Nguyen TT. Isolated intracranial infection with mycobacterium avium complex. J Neurosurg Sci. 2003;47(2):101–5. discussion 5.PubMed Dickerman RD, Stevens QE, Rak R, Dorman SE, Holland SM, Nguyen TT. Isolated intracranial infection with mycobacterium avium complex. J Neurosurg Sci. 2003;47(2):101–5. discussion 5.PubMed
22.
go back to reference Fritscher LG, Marras TK, Bradi AC, Fritscher CC, Balter MS, Chapman KR. Nontuberculous mycobacterial infection as a cause of difficult-to-control asthma: a case–control study. Chest. 2011;139(1):23–7.PubMedCrossRef Fritscher LG, Marras TK, Bradi AC, Fritscher CC, Balter MS, Chapman KR. Nontuberculous mycobacterial infection as a cause of difficult-to-control asthma: a case–control study. Chest. 2011;139(1):23–7.PubMedCrossRef
23.
go back to reference Dirac MA, Horan KL, Doody DR, Meschke JS, Park DR, Jackson LA, et al. Environment or host?: a case–control study of risk factors for mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2012;186(7):684–91.PubMedCrossRef Dirac MA, Horan KL, Doody DR, Meschke JS, Park DR, Jackson LA, et al. Environment or host?: a case–control study of risk factors for mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2012;186(7):684–91.PubMedCrossRef
24.
go back to reference Kobashi Y, Matsushima T. Clinical analysis of pulmonary mycobacterium avium complex disease in association with corticosteroid treatment. J Infect Chemother Off J Jpn Soc Chemother. 2003;9(1):68–74.CrossRef Kobashi Y, Matsushima T. Clinical analysis of pulmonary mycobacterium avium complex disease in association with corticosteroid treatment. J Infect Chemother Off J Jpn Soc Chemother. 2003;9(1):68–74.CrossRef
25.
go back to reference Browne SK, Zaman R, Sampaio EP, Jutivorakool K, Rosen LB, Ding L, et al. Anti-CD20 (rituximab) therapy for anti-IFN-gamma autoantibody-associated nontuberculous mycobacterial infection. Blood. 2012;119(17):3933–9.PubMedCentralPubMedCrossRef Browne SK, Zaman R, Sampaio EP, Jutivorakool K, Rosen LB, Ding L, et al. Anti-CD20 (rituximab) therapy for anti-IFN-gamma autoantibody-associated nontuberculous mycobacterial infection. Blood. 2012;119(17):3933–9.PubMedCentralPubMedCrossRef
Metadata
Title
The First US Domestic Report of Disseminated Mycobacterium avium Complex and Anti-Interferon-γ Autoantibodies
Authors
Elise O’Connell
Lindsey B. Rosen
Richard W. LaRue
Valeria Fabre
Michael T. Melia
Paul G. Auwaerter
Steven M. Holland
Sarah K. Browne
Publication date
01-11-2014
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 8/2014
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-014-0073-9

Other articles of this Issue 8/2014

Journal of Clinical Immunology 8/2014 Go to the issue

Announcement

Announcement

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.